SCHEMBL6765169

SCHEMBL6765169

COc1ccc(-n2ccnc2SCc2ccccc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 7/20 0.67
CYP3A4 P08684 7/20 0.67
CYP2C9 P11712 7/20 0.67
CYP2C19 P33261 7/20 0.67
CYP2D6 P10635 5/20 0.67
L3MBTL1 Q9Y468 5/20 0.67
ALOX15B O15296 3/20 0.67
GAA P10253 1/20 0.67
TSHR P16473 3/20 0.61
RAB9A P51151 3/20 0.57
NPC1 O15118 2/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
TP53 P04637 2/20 0.55
ALDH1A1 P00352 3/20 0.54
POLB P06746 1/20 0.53
THRB P10828 1/20 0.53
LMNA P02545 2/20 0.52
NPSR1 Q6W5P4 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
ALOX15 P16050 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9431436 0.86 POLB (0.56) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL24944906 0.81 CYP1A2 (1.00) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
Hydrochloric Acid SCHEMBL11376841 0.81 CYP1A2 (0.57) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL10424919 0.79 TSHR (0.71) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL10399742 0.78 TSHR (0.55) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
Hydrochloric Acid SCHEMBL11385536 0.78 CYP1A2 (0.55) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL24945027 0.77 CYP1A2 (0.78) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL24944905 0.77 CYP3A4 (1.00) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL24943934 0.77 L3MBTL1 (0.77) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
Hydrochloric Acid SCHEMBL11387397 0.76 NR4A1 (0.57) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6730796-B2 REACTING ISOTHIOCYANATE WITH -AMINOCARBONYL COMPOUND AND ALKYL HALIDE OR ACTIVATED ARYL HALIDE; CYCLIZATION CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2004-05-04 US disclosed
US-20040039210-A1 PROCESS FOR PREPARATION OF N-SUBSTITUTED 2-SULFANYLIMIDAZOLES CHENG JIE FEI (US) 2004-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040039210-A1 PROCESS FOR PREPARATION OF N-SUBSTITUTED 2-SULFANYLIMIDAZOLES TST, STS, AADAC CYP1A2 1264/4885CYP3A4 497/4885CYP2C9 1271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.